Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellectis S.A., a foreign private issuer, is dated May 24, 2024. The report serves to notify shareholders and the market of the upcoming Combined General Meeting of Shareholders scheduled for June 28, 2024, at 2:30 p.m. Paris time at the Biopark auditorium in Paris, France.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the logistics for the shareholder meeting and incorporates the Notice of Combined General Meeting of Shareholders as an exhibit.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The primary content is the announcement of the meeting date, time, and location, along with the attached text of resolutions for shareholder approval.
Key Facts for Investor Verification
- Verify the date and time of the Combined General Meeting of Shareholders: June 28, 2024, at 2:30 p.m. Paris time.
- Confirm the meeting location: Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.
- Review the attached Exhibit 99.1 (Notice of Combined Shareholders' Meeting) for the specific text of resolutions to be voted upon.
- Note that this filing does not include updated financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial data.